Search

everythinglearnresearchcommunity

for

Search:↓

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

ROXY proteins help plants respond to nitrate shortage by affecting nutrient sensing and growth.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

A weight loss program with a special fast helped patients lose an average of 41-47 pounds and improved their health, but maintaining the weight loss was challenging.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

Troxerutin helps protect skin cells from oxidative stress and may be good for treating hair loss.

More research is needed to understand how nutrients affect root hair growth.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Activating β-catenin in mammary cells leads to changes that cause early-stage abnormal growths similar to skin structures.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Injecting platelet-derived growth factors into ovaries may improve IVF outcomes by enhancing egg quality and embryo health.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.